Skip to main content
All lobbying filings

TIBER CREEK GROUP

Lobbying for TAKEDA PHARMACEUTICALS AMERICA, INC. · Pharmaceutical company.

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jul 19, 2025

Official filing document

 Lobbying activity 1
Medicare/Medicaid

Issues related to Medicare Part D and Part B Pricing Reform.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem